Valion Bio Inc (VBIO)

Valion Bio Inc (VBIO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.2M; returns 1 day -1.7%, 1 week -19.7%.

Valion Bio Inc (VBIO) is a clinical-stage biotechnology company primarily focused on developing next-generation immunotherapies for solid tumors and rare autoimmune disorders. As of May 2026, the company's revenue model remains pre-commercial, driven largely by strategic partnerships, research grants, and milestone payments from larger pharmaceutical entities.

Groups VBIO belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Oncology
• Immunotherapy
• Autoimmune Diseases
• Clinical Stage
• AI in Healthcare
• Healthcare Innovation

VBIO financial model: income statement, cash flow and balance sheet